Onur Atasoylu, PhD
Onur Atasoylu, PhD
Incyte Corporation
Verified email at uea.ac.uk
Cited by
Cited by
W3 theory: Robust computational thermochemistry in the kJ/mol accuracy range
AD Boese, M Oren, O Atasoylu, JML Martin, M Kállay, J Gauss
The Journal of chemical physics 120 (9), 4129-4141, 2004
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
TL Yeh, TM Leissing, MI Abboud, CC Thinnes, O Atasoylu, JP Holt-Martyn, ...
Chemical science 8 (11), 7651-7668, 2017
Tetrazine phototriggers: Probes for peptide dynamics
MJ Tucker, JR Courter, J Chen, O Atasoylu, AB Smith III, RM Hochstrasser
Angewandte Chemie 122 (21), 3694-3698, 2010
Spongipyran synthetic studies. Evolution of a scalable total synthesis of (+)-spongistatin 1
AB Smith III, C Sfouggatakis, CA Risatti, JB Sperry, W Zhu, VA Doughty, ...
Tetrahedron 65 (33), 6489-6509, 2009
Interactions of halichondrin B and eribulin with tubulin
R Bai, TL Nguyen, JC Burnett, O Atasoylu, MHG Munro, GR Pettit, ...
Journal of chemical information and modeling 51 (6), 1393-1404, 2011
sp3 C–H and sp2 C–H agostic ruthenium complexes: a combined experimental and theoretical study
ME Van Der Boom, MA Iron, O Atasoylu, LJW Shimon, H Rozenberg, ...
Inorganica chimica acta 357 (6), 1854-1864, 2004
Total Synthesis of (−)-2-epi-Peloruside A
AB Smith III, JM Cox, N Furuichi, CS Kenesky, J Zheng, O Atasoylu, ...
Organic letters 10 (24), 5501-5504, 2008
Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain
MC Chan, O Atasoylu, E Hodson, A Tumber, IKH Leung, R Chowdhury, ...
PLoS One 10 (7), e0132004, 2015
Design and synthesis of (+)-discodermolide–paclitaxel hybrids leading to enhanced biological activity
AB Smith III, K Sugasawa, O Atasoylu, CPH Yang, SB Horwitz
Journal of medicinal chemistry 54 (18), 6319-6327, 2011
Cyclopentane-1, 3-dione: a novel isostere for the carboxylic acid functional group. Application to the design of potent thromboxane (A2) receptor antagonists
C Ballatore, JH Soper, F Piscitelli, M James, L Huang, O Atasoylu, ...
Journal of medicinal chemistry 54 (19), 6969-6983, 2011
Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned
AB Smith III, CA Risatti, O Atasoylu, CS Bennett, J Liu, H Cheng, ...
Journal of the American chemical society 133 (35), 14042-14053, 2011
The solution structure of (+)-spongistatin 1 in DMSO
O Atasoylu, G Furst, C Risatti, AB Smith III
Organic letters 12 (8), 1788-1791, 2010
Design, synthesis, and biological evaluation of EF-and ABEF-analogues of (+)-spongistatin 1
AB Smith III, CA Risatti, O Atasoylu, CS Bennett, K TenDyke, Q Xu
Organic letters 12 (8), 1792-1795, 2010
In vitro and in vivo anticancer activity of (+)-spongistatin 1
Q Xu, KC Huang, K Tendyke, J Marsh, J Liu, D Qiu, BA Littlefield, ...
Anticancer research 31 (9), 2773-2779, 2011
Construction of 5, 6-Ring Fused 2-Pyridones: An Effective Annulation Tactic Achieved in Water
AB Smith III, O Atasoylu, DC Beshore
Synlett: accounts and rapid communications in synthetic organic chemistry …, 2009
L.; Kállay, M.; Gauss
M Oren, O Atasoylu, JM Martin
J. Chem. Phys 120, 4129, 2004
Investigation of structure–spectroscopy–function relationship of two-dimensional J-aggregates of tetrachlorobenzimidazolocarbocyanine preferentially oriented in poly-vinyl …
D Gülen, O Atasoylu, S Özçelik
Chemical Physics 355 (1), 73-80, 2009
Cyanoindazole compounds and uses thereof
O Vechorkin, O Atasoylu, HF Ye, K Liu, K Zhang, W Yao
US Patent 10,722,495, 2020
Improved dose-response relationship of (+)-discodermolide-taxol hybrid congeners
C Nadaradjane, CPH Yang, A Rodriguez-Gabin, K Ye, K Sugasawa, ...
Journal of natural products 81 (3), 607-615, 2018
Cycloalkyl-dione derivatives and methods of their use
O Atasoylu, C Ballatore, KR Brunden, L Huang, DM Huryn, M James, ...
US Patent 8,530,520, 2013
The system can't perform the operation now. Try again later.
Articles 1–20